Latest common stock for NMRD: $29K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Nemaura Medical (NMRD) currently reports a common stock of $29K as of December 2023. That compares with $24K in the prior-year period — up 19.9% year over year. Use the charts on this page to explore Nemaura Medical's common stock history and peer comparisons.
Nemaura Medical's common stock increased from $24K to $29K — a 19.9% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Nemaura Medical reported $29K in common stock as of December 2023. That compares with $24K in the prior-year period — up 19.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $29K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nemaura Medical, and consider following NMRD for alerts when major investors trade the stock.
Nemaura Medical is classified in the Healthcare sector. On common stock, it currently shows $29K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NMRD with unrelated industries.